Natalie J Ives

Summary

Affiliation: University of Birmingham
Country: UK

Publications

  1. pmc Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial
    Michael Walsh
    Departments of Medicine and Clinical Epidemiology and Biostatistics, Marian Wing, Division of Nephrology, McMaster University, St, Joseph s Hospital, 50 Charlton Ave East, Hamilton, ON L8S 4A6, Canada
    Trials 14:73. 2013
  2. pmc Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
    Adrian Williams
    Queen Elizabeth Hospital, Birmingham, Birmingham, UK
    Lancet Neurol 9:581-91. 2010
  3. ncbi request reprint Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials
    Natalie J Ives
    Birmingham Clinical Trials Unit, The University of Birmingham, Park Grange, 1 Somerset Road, Edgbaston, Birmingham B15 2RR, UK
    Nephrol Dial Transplant 18:298-304. 2003
  4. pmc Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2RR
    BMJ 329:593. 2004
  5. ncbi request reprint Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, Division of Medical Sciences, Robert Aitken Institute, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    J Clin Oncol 25:5426-34. 2007
  6. pmc Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials
    Dwomoa Adu
    Department of Nephrology, Queen Elizabeth Hospital, Birmingham, B15 2TH
    BMJ 326:789. 2003
  7. ncbi request reprint High-dose chemotherapy for breast cancer
    Keith Wheatley
    N Engl J Med 349:1476-9; author reply 1476-9. 2003
  8. ncbi request reprint Does adjuvant vaccine therapy really have activity in malignant melanoma?
    Keith Wheatley
    J Clin Oncol 25:4693; author reply 4693-5. 2007

Collaborators

Detail Information

Publications8

  1. pmc Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial
    Michael Walsh
    Departments of Medicine and Clinical Epidemiology and Biostatistics, Marian Wing, Division of Nephrology, McMaster University, St, Joseph s Hospital, 50 Charlton Ave East, Hamilton, ON L8S 4A6, Canada
    Trials 14:73. 2013
    ..A randomized study of both plasma exchange and glucocorticoids is required to evaluate plasma exchange and oral glucocorticoid dosing in patients with AAV...
  2. pmc Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
    Adrian Williams
    Queen Elizabeth Hospital, Birmingham, Birmingham, UK
    Lancet Neurol 9:581-91. 2010
    ..We aimed to assess whether surgery and best medical therapy improved self-reported quality of life more than best medical therapy alone in patients with advanced Parkinson's disease...
  3. ncbi request reprint Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials
    Natalie J Ives
    Birmingham Clinical Trials Unit, The University of Birmingham, Park Grange, 1 Somerset Road, Edgbaston, Birmingham B15 2RR, UK
    Nephrol Dial Transplant 18:298-304. 2003
    ..To study the effect of revascularization on blood pressure (BP) and serum creatinine (SCr) in patients with atherosclerotic renovascular disease (ARVD)...
  4. pmc Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2RR
    BMJ 329:593. 2004
    ..To quantify more reliably the benefits and risks of monoamine oxidase type B inhibitors (MAOBIs) in early Parkinson's disease...
  5. ncbi request reprint Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, Division of Medical Sciences, Robert Aitken Institute, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    J Clin Oncol 25:5426-34. 2007
    ..The only subgroup analysis performed was by type of immunotherapy, with trials divided according to whether IFN only or IFN and IL-2 were administered in the biochemotherapy arm...
  6. pmc Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials
    Dwomoa Adu
    Department of Nephrology, Queen Elizabeth Hospital, Birmingham, B15 2TH
    BMJ 326:789. 2003
    ..To study the effect of interleukin-2 receptor monoclonal antibodies on acute rejection episodes, graft loss, deaths, and rate of infection and malignancy in patients with renal transplants...
  7. ncbi request reprint High-dose chemotherapy for breast cancer
    Keith Wheatley
    N Engl J Med 349:1476-9; author reply 1476-9. 2003
  8. ncbi request reprint Does adjuvant vaccine therapy really have activity in malignant melanoma?
    Keith Wheatley
    J Clin Oncol 25:4693; author reply 4693-5. 2007